Literature DB >> 26405852

Critical Analysis of Hospital Readmission and Cost Burden After Robot-Assisted Radical Cystectomy.

Kristina Wittig1, Nora Ruel1, John Barlog1, Laura Crocitto1, Kevin Chan1, Clayton Lau1, Timothy Wilson1, Bertram Yuh1.   

Abstract

OBJECTIVE: To examine the occurrence and cost burden of hospital readmission within 90 days of robot-assisted radical cystectomy (RARC). Subjects/Patients (or Materials) and
Methods: From 2003 to 2012, 247 patients underwent RARC with extracorporeal urinary reconstruction at a single categorical cancer hospital. Continent diversions were performed in 67% of patients. All readmissions within 90 days were included. Readmissions were defined as early (<30 days) and late (31-90 days) with multiple readmissions captured as separate events. Cost analysis was performed using average direct hospital cost. The Fisher exact test was used to determine differences in proportion of readmissions between patient groups, while logistic regression was used to identify predictors for readmission.
RESULTS: Ninety-eight (40%) patients were readmitted to the hospital at least once within 90 days after RARC, of which 77% occurred within 30 days. Twenty-seven (11%) required two or more readmissions. Readmissions took place at a median of 13 days after initial discharge. The most common reasons for initial readmission were infections (41%) and dehydration (19%). Stratified by urinary reconstruction type, ileal conduit (dehydration), Indiana pouch (urinary-tract infection without sepsis), and Studer neobladder (sepsis and pelvic abscess) differed by readmission reason. In a multivariable analysis, estimated blood loss was a predictor for readmission (p = 0.05). Patients readmitted to the hospital had direct costs that were 1.42× those who did not require readmission. Readmissions for ileus contributed to the highest cost of readmission, although ureteral stricture, pelvic abscess, and sepsis were the most costly per day of hospitalization. Limitations include retrospective analysis as well as variable thresholds for readmission and costs.
CONCLUSIONS: Hospital readmission rates after RARC are high and costs of readmission are significant. Most patients are readmitted within 30 days and infection and dehydration are common causes. Clinicians should be aware of diversion-specific readmission causes.

Entities:  

Mesh:

Year:  2015        PMID: 26405852     DOI: 10.1089/end.2015.0438

Source DB:  PubMed          Journal:  J Endourol        ISSN: 0892-7790            Impact factor:   2.942


  8 in total

1.  Open versus robot-assisted radical cystectomy: 30-day perioperative comparison and predictors for cost-to-patient, complication, and readmission.

Authors:  Jason F Flamiatos; Yiyi Chen; William E Lambert; Ann Martinez Acevedo; Thomas M Becker; Jasper C Bash; Christopher L Amling
Journal:  J Robot Surg       Date:  2018-06-08

Review 2.  Intracorporeal versus extracorporeal urinary diversion following robot-assisted radical cystectomy: a meta-analysis, cumulative analysis, and systematic review.

Authors:  Karthik Tanneru; Seyed Behzad Jazayeri; Jatinder Kumar; Muhammad Umar Alam; Daniel Norez; Sabine Nguyen; Soroush Bazargani; Hariharan Palayapalayam Ganapathi; Mark Bandyk; Robert Marino; Shahriar Koochekpour; Shiva Gautam; K C Balaji; Joseph Costa
Journal:  J Robot Surg       Date:  2020-11-22

3.  Urinary tract infections following radical cystectomy and urinary diversion: a review of 1133 patients.

Authors:  Thomas G Clifford; Behrod Katebian; Christine M Van Horn; Soroush T Bazargani; Jie Cai; Gus Miranda; Siamak Daneshmand; Hooman Djaladat
Journal:  World J Urol       Date:  2018-01-25       Impact factor: 4.226

4.  Readmission Rate and Causes at 90-Day after Radical Cystectomy in Patients on Early Recovery after Surgery Protocol.

Authors:  Emanuela Altobelli; Maurizio Buscarini; Harcharan S Gill; Eila C Skinner
Journal:  Bladder Cancer       Date:  2017-01-27

Review 5.  Bioengineering Approaches for Bladder Regeneration.

Authors:  Ángel Serrano-Aroca; César David Vera-Donoso; Victoria Moreno-Manzano
Journal:  Int J Mol Sci       Date:  2018-06-17       Impact factor: 5.923

6.  Feasibility of wearable activity trackers in cystectomy patients to monitor for postoperative complications.

Authors:  Austen D Slade; James R Cardinal; Christopher R Martin; Angela P Presson; Chelsea D Allen; William T Lowrance; Christopher B Dechet; Brock B O'Neil
Journal:  Curr Urol       Date:  2021-06-24

7.  Bladder Cancer Recovery Pathways: A Systematic Review.

Authors:  Ian Maloney; Daniel C Parker; Michael S Cookson; Sanjay Patel
Journal:  Bladder Cancer       Date:  2017-10-27

8.  Impact of radiation on the incidence and management of ureteroenteric strictures: a contemporary single center analysis.

Authors:  Clinton T Yeaman; Andrew Winkelman; Kimberly Maciolek; Mei Tuong; Perri Nelson; Chandler Morris; Stephen Culp; Sumit Isharwal; Tracey L Krupski
Journal:  BMC Urol       Date:  2021-08-04       Impact factor: 2.264

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.